ML
Insider
Michel Lagarde
Executive Vice President & COOMichel Lagarde (Executive Vice President & COO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Thermo Fisher Scientific Inc. (TMO). The largest single filing was $36.1M of TMO (62,000 sh across 3 lots, as filed), executed Dec 2 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$51.3M
shares × price, as filed
Last traded
Dec 4 2025
Filed Dec 5 2025
Median ADV $1.4B across their filed names
Open performance→Volume by month
Buys $0
Sells $51.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
TMORecent filings
TMOSALE
Thermo Fisher Scientific Inc.
View filing →
$12.4M22,046 sh × $563.56
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET TMOSALE Thermo Fisher Scientific Inc. View filing → $36.1M
62,000 sh across 3 lots
Exec Dec 2 2025
Filed Dec 4 2025 · 5:30 PM ET TMOSALE Thermo Fisher Scientific Inc. View filing → $2.8M
4,638 sh × $594.42
Exec Nov 13 2025
Filed Nov 14 2025 · 5:30 PM ET